Two days after the Supreme Court of India issued a contempt notice against Patanjali Ayurveda and banned it from issuing misleading ads carrying claims of treating certain diseases, the company today informed the Bombay Stock Exchange (BSE) that the court observations do not have any bearing on the regular business operation or the financial performance of Patanjali Foods Limited.

In a BSE filing, the company wrote, "The observations of the Supreme Court of India do not relate to Patanjali Foods Limited (PFL) which is an independent listed entity and operates in the space of edible oil and food FMCG products only. The observations do not have any bearing on the regular business operation or the financial performance of Patanjali Foods Limited."

On February 27, the apex court issued a contempt of court notice to Baba Ramdev-owned Patanjali Ayurveda and its Managing Director Acharya Balakrishnan for violating its earlier order against misleading advertisements that talk about curing serious diseases or making claims against allopathy.

The court had in November last year issued a notice to Patanjali Ayurveda directing it to not issue any misleading advertisements or make statements adverse to allopathy, in response to a plea filed by the Indian Medical Association (IMA). In the plea, the IMA had accused Patanjali of defaming evidence-based medicine. The petition by IMA requested court to control the "smear campaign" and negative advertisements against the vaccination drive and modern medicines.

The next hearing in the case will be held in two weeks.